$0.6924
-0.0323-4.46%
Last update: Nov 3, 4:40 PM
Hyperfine Inc (HYPR) Stock Price, Quote, News & History
HYPRNASDAQ
Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform ratings and price targets. See other analysts' views.
You can purchase shares of Hyperfine (NASDAQ:HYPR) through any online brokerage.
Other companies in Hyperfine’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Hyperfine has a consensus price target of $1.70.
The stock price for Hyperfine (NASDAQ: HYPR) is $0.69 last updated November 3, 2026 at 4:40 PM EST.
There are no upcoming dividends for Hyperfine.
Hyperfine does not have any upcoming earnings scheduled.
There is no upcoming split for Hyperfine.
Hyperfine is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of...
